Gilead CEO Daniel O'Day on new HIV prevention medicine: It's going to change the face of HIV

Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV

Gilead CEO Daniel O'Day on remdesivir pricing and ensuring access to treatment

Grand Keynote I Daniel O'Day, Gilead Sciences Inc and Rich Karlgaard I TiEcon 2021

Gilead Sciences CEO Daniel O'Day on HIV prevention injection approval

Gilead Science | Covid -19 Treatment | CEO Daniel O' Day Speech | Pharma Industry

Daniel O’Day of Gilead Sciences, Inc. on COVID-19 Efforts